Axogen, Inc. Deferred Tax Liabilities, Gross
Axogen, Inc. (AXGN) had Deferred Tax Liabilities, Gross of $5.47 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-24
- 2025-12-31: Deferred Tax Liabilities, Gross $5.47M.
- 2024-12-31: Deferred Tax Liabilities, Gross $4.84M.
- 2023-12-31: Deferred Tax Liabilities, Gross $5.06M.
- 2022-12-31: Deferred Tax Liabilities, Gross $4.74M.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $5.47M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $4.84M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $5.06M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $4.74M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $4.67M 10-K · filed 2023-03-14 | |
| 2020-12-31 | $5.19M 10-K · filed 2022-02-25 | |
| 2015-12-31 | $62.40K 10-K · filed 2016-02-29 | |
| 2014-12-31 | $85.70K 10-K · filed 2016-02-29 | -$37.80K 10-K · filed 2015-03-05 |
| 2013-12-31 | -$36.90K 10-K · filed 2015-03-05 | |
| 2012-12-31 | $206.60K 10-K · filed 2014-03-06 | |
| 2011-12-31 | $211.00K 10-K/A · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |